Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stauffer Larsen

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 21, 2007
Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemiaThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
Critical Reviews in Oncology/Hematology|April 18, 2021
Prognostic models in primary central nervous system lymphoma patients: A systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Zoran Bukumiric, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2022
Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic ReviewJelena Jelicic, Thomas Stauffer Larsen, Annette Dam Fialla, et al.
Critical Reviews in Oncology/Hematology|February 12, 2024
Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Bosko Andjelic, et al.
Clinical Epidemiology|June 26, 2020
Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models - A Systematic ReviewJelena Jelicic, Thomas Stauffer Larsen, Henrik Frederiksen, et al.
Hematology (Amsterdam, Netherlands)|January 22, 2009
Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burdenThomas Stauffer Larsen, Niels Pallisgaard, Karin de Stricker, et al.
Cancers|September 28, 2021
Harnessing the Immune System to Fight Multiple MyelomaJakub Krejcik, Mike Bogetofte Barnkob, Charlotte Guldborg Nyvold, et al.
Current Drug Targets|December 15, 2010
Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectivesHans Carl Hasselbalch, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, et al.
European Journal of Haematology|November 20, 2018
Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasmsMette Brabrand, Knud Nørregaard Hansen, Christian B Laursen, et al.
Case Reports in Oncology|February 21, 2025
Disseminated Marginal Zone Lymphoma in a Patient with Lyme Neuroborreliosis: A Case ReportDorit Kraft Weisbjerg, Sigurdur Skarphedinsson, Nanna Skaarup Andersen, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 21, 2007
Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemiaThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
Critical Reviews in Oncology/Hematology|April 18, 2021
Prognostic models in primary central nervous system lymphoma patients: A systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Zoran Bukumiric, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2022
Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic ReviewJelena Jelicic, Thomas Stauffer Larsen, Annette Dam Fialla, et al.
Critical Reviews in Oncology/Hematology|February 12, 2024
Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Bosko Andjelic, et al.
Clinical Epidemiology|June 26, 2020
Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models - A Systematic ReviewJelena Jelicic, Thomas Stauffer Larsen, Henrik Frederiksen, et al.
Hematology (Amsterdam, Netherlands)|January 22, 2009
Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burdenThomas Stauffer Larsen, Niels Pallisgaard, Karin de Stricker, et al.
Cancers|September 28, 2021
Harnessing the Immune System to Fight Multiple MyelomaJakub Krejcik, Mike Bogetofte Barnkob, Charlotte Guldborg Nyvold, et al.
Current Drug Targets|December 15, 2010
Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectivesHans Carl Hasselbalch, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, et al.
European Journal of Haematology|November 20, 2018
Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasmsMette Brabrand, Knud Nørregaard Hansen, Christian B Laursen, et al.
Case Reports in Oncology|February 21, 2025
Disseminated Marginal Zone Lymphoma in a Patient with Lyme Neuroborreliosis: A Case ReportDorit Kraft Weisbjerg, Sigurdur Skarphedinsson, Nanna Skaarup Andersen, et al.
Pageof 10